SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2,660.63 |
| Enterprise Value ($M) | 2,033.72 |
| Book Value ($M) | 754.90 |
| Book Value / Share | 9.86 |
| Price / Book | 3.52 |
| NCAV ($M) | 592.03 |
| NCAV / Share | 7.73 |
| Price / NCAV | 4.49 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.31 |
| Return on Assets (ROA) | -0.24 |
| Return on Equity (ROE) | -0.25 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 17.85 |
| Current Ratio | 17.85 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 635.26 |
| Assets | 798.14 |
| Liabilities | 43.24 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -279.30 |
| Net Income | -234.33 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -181.39 |
| Cash from Investing | 165.00 |
| Cash from Financing | 12.13 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Fmr Llc | 10.30 | 14.32 | |
| 13G/A | Driehaus Capital Management Llc | 5.88 | -7.19 | |
| 13G/A | Avoro Capital Advisors LLC | 7.70 | 15.65 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 45,338 | 249,531 | 18.17 | |
| 135,944 | 583,495 | 23.30 | |
| 69,278 | 362,147 | 19.13 | |
| 91,725 | 562,630 | 16.30 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| VNDA – Vanda Pharmaceuticals Inc. | VRCA – Verrica Pharmaceuticals Inc. |
| WVE – Wave Life Sciences Ltd. | XNCR – Xencor, Inc. |
| XOMA – XOMA Royalty Corporation |
Financial data and stock pages provided by
Fintel.io